News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
506,003 Results
Type
Article (29371)
Company Profile (82)
Press Release (476550)
Multimedia
Podcasts (27)
Webinars (9)
Section
Business (149040)
Career Advice (841)
Deals (25648)
Drug Delivery (57)
Drug Development (56481)
Employer Resources (71)
FDA (13367)
Job Trends (10834)
News (249965)
Policy (23382)
Tag
Academia (1892)
Accelerated approval (4)
Adcomms (9)
Allergies (77)
Alliances (34557)
ALS (63)
Alzheimer's disease (944)
Antibody-drug conjugate (ADC) (70)
Approvals (13435)
Artificial intelligence (192)
Autoimmune disease (14)
Automation (7)
Bankruptcy (213)
Best Places to Work (8604)
BIOSECURE Act (5)
Biosimilars (42)
Biotechnology (62)
Bladder cancer (64)
Brain cancer (20)
Breast cancer (213)
Cancer (1648)
Cardiovascular disease (125)
Career advice (740)
Career pathing (15)
CAR-T (90)
Cell therapy (260)
Cervical cancer (14)
Clinical research (47426)
Collaboration (534)
Compensation (269)
Complete response letters (10)
COVID-19 (1661)
CRISPR (14)
C-suite (189)
Cystic fibrosis (51)
Data (1736)
Decentralized trials (2)
Denatured (17)
Depression (35)
Diabetes (200)
Diagnostics (4667)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (22)
Drug discovery (70)
Drug pricing (55)
Drug shortages (22)
Duchenne muscular dystrophy (65)
Earnings (60789)
Editorial (20)
Employer branding (12)
Employer resources (68)
Events (76475)
Executive appointments (604)
FDA (14441)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (527)
Gene editing (44)
Generative AI (12)
Gene therapy (167)
GLP-1 (476)
Government (3214)
Grass and pollen (3)
Guidances (47)
Healthcare (14801)
Huntington's disease (11)
IgA nephropathy (17)
Immunology and inflammation (48)
Indications (22)
Infectious disease (1736)
Inflammatory bowel disease (89)
Inflation Reduction Act (5)
Influenza (26)
Intellectual property (58)
Interviews (91)
IPO (11868)
IRA (20)
Job creations (2568)
Job search strategy (676)
Kidney cancer (8)
Labor market (13)
Layoffs (239)
Leadership (9)
Legal (5165)
Liver cancer (60)
Lung cancer (244)
Lymphoma (116)
Machine learning (3)
Management (24)
Manufacturing (145)
MASH (55)
Medical device (13325)
Medtech (13330)
Mergers & acquisitions (14190)
Metabolic disorders (484)
Multiple sclerosis (59)
NASH (12)
Neurodegenerative disease (53)
Neuropsychiatric disorders (11)
Neuroscience (1318)
NextGen: Class of 2025 (4783)
Non-profit (3249)
Now hiring (18)
Obesity (240)
Opinion (96)
Ovarian cancer (59)
Pain (68)
Pancreatic cancer (63)
Parkinson's disease (101)
Partnered (17)
Patents (124)
Patient recruitment (92)
Peanut (40)
People (46621)
Pharmaceutical (22)
Pharmacy benefit managers (11)
Phase I (13944)
Phase II (20724)
Phase III (16468)
Pipeline (928)
Policy (65)
Postmarket research (1907)
Preclinical (4938)
Press Release (69)
Prostate cancer (85)
Psychedelics (22)
Radiopharmaceuticals (198)
Rare diseases (220)
Real estate (3996)
Recruiting (24)
Regulatory (16608)
Reports (20)
Research institute (1754)
Resumes & cover letters (106)
Rett syndrome (5)
RNA editing (3)
RSV (20)
Schizophrenia (59)
Series A (84)
Series B (59)
Service/supplier (4)
Sickle cell disease (24)
Special edition (4)
Spinal muscular atrophy (112)
Sponsored (17)
Startups (2592)
State (1)
Stomach cancer (9)
Supply chain (44)
Tariffs (15)
The Weekly (10)
Vaccines (387)
Venture capitalists (14)
Weight loss (154)
Women's health (17)
Worklife (4)
Date
Today (89)
Last 7 days (595)
Last 30 days (1838)
Last 365 days (23798)
2025 (7719)
2024 (25893)
2023 (29952)
2022 (39538)
2021 (42697)
2020 (41185)
2019 (35077)
2018 (26762)
2017 (24153)
2016 (23172)
2015 (27832)
2014 (21486)
2013 (17902)
2012 (19262)
2011 (19780)
2010 (18595)
Location
Africa (479)
Alabama (24)
Alaska (4)
Arizona (141)
Arkansas (10)
Asia (29675)
Australia (4607)
California (4180)
Canada (1683)
China (412)
Colorado (195)
Connecticut (201)
Delaware (125)
Europe (61155)
Florida (669)
Georgia (142)
Idaho (45)
Illinois (427)
India (18)
Indiana (253)
Iowa (5)
Japan (145)
Kansas (82)
Kentucky (21)
Louisiana (8)
Maine (64)
Maryland (719)
Massachusetts (3047)
Michigan (173)
Minnesota (340)
Mississippi (2)
Missouri (66)
Montana (27)
Nebraska (23)
Nevada (50)
New Hampshire (62)
New Jersey (1403)
New Mexico (15)
New York (1244)
North Carolina (753)
North Dakota (6)
Northern California (1864)
Ohio (149)
Oklahoma (8)
Oregon (24)
Pennsylvania (1012)
Puerto Rico (9)
Rhode Island (27)
South America (728)
South Carolina (22)
Southern California (1571)
Tennessee (86)
Texas (660)
United States (16666)
Utah (146)
Virginia (108)
Washington D.C. (43)
Washington State (318)
West Virginia (3)
Wisconsin (59)
506,003 Results for "profound medical corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
April 17, 2025
·
2 min read
Press Releases
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
March 6, 2025
·
16 min read
Business
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
Profound Medical Corp. will announce its first quarter 2024 financial results after market close on Thursday, May 9, 2024.
April 22, 2024
·
2 min read
Press Releases
Profound Medical Standardizes on AcuityMD Intelligence Platform for MedTech as Foundation for Growing Organization
February 26, 2025
·
3 min read
Press Releases
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
February 14, 2025
·
2 min read
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
Profound Medical Corp. announced that it has entered into a non-exclusive collaboration with Siemens Healthineers, a global leader in medical technology.
February 27, 2024
·
7 min read
Business
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full year ended December 31, 2023.
March 7, 2024
·
13 min read
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Profound Medical Corp. today announced that management will present an update on the Company’s business at the 2024 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024 at 9:30 a.m. Eastern Time at the Metro Toronto Convention.
April 9, 2024
·
2 min read
Press Releases
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
4 min read
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced that management will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13, 2024 at 11:15 a.m. Eastern Time at the Loews Miami Beach Hotel.
March 4, 2024
·
2 min read
1 of 50,601
Next
